Peer Review History
| Original SubmissionDecember 30, 2024 |
|---|
|
Dear Dr. Rodgers, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Thank you for your valuable submission. This is an important and well-conducted study, though some concerns need to be addressed. I encourage the authors to check all comments carefully and ensure the rebuttal clearly highlights the changes made, providing justifications for both changes and aspects left unchanged. Please respond all comments and highlight in the ms. Wishing you success with the study. Please submit your revised manuscript by May 05 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Thiago P. Fernandes, PhD Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements.-->--> -->-->Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at -->-->https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and -->-->https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf-->--> -->-->2. Thank you for stating in your Funding Statement: -->-->This work was supported by the Wellcome Trust via a Health Advances in Underrepresented Populations and Diseases (HARP) Fellowship, awarded to Lucy Rodgers. Grant no. 223500/Z/21/Z. -->--> -->-->Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now. Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. -->-->Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf.-->--> -->-->3. We note that this data set consists of interview transcripts. Can you please confirm that all participants gave consent for interview transcript to be published?-->--> -->-->If they DID provide consent for these transcripts to be published, please also confirm that the transcripts do not contain any potentially identifying information (or let us know if the participants consented to having their personal details published and made publicly available). We consider the following details to be identifying information:-->-->- Names, nicknames, and initials-->-->- Age more specific than round numbers-->-->- GPS coordinates, physical addresses, IP addresses, email addresses-->-->- Information in small sample sizes (e.g. 40 students from X class in X year at X university)-->-->- Specific dates (e.g. visit dates, interview dates)-->-->- ID numbers-->--> -->-->Or, if the participants DID NOT provide consent for these transcripts to be published:-->-->- Provide a de-identified version of the data or excerpts of interview responses-->-->- Provide information regarding how these transcripts can be accessed by researchers who meet the criteria for access to confidential data, including:-->-->a) the grounds for restriction-->-->b) the name of the ethics committee, Institutional Review Board, or third-party organization that is imposing sharing restrictions on the data-->-->c) a non-author, institutional point of contact that is able to field data access queries, in the interest of maintaining long-term data accessibility.-->-->d) Any relevant data set names, URLs, DOIs, etc. that an independent researcher would need in order to request your minimal data set.-->--> -->-->For further information on sharing data that contains sensitive participant information, please see: https://journals.plos.org/plosone/s/data-availability#loc-human-research-participant-data-and-other-sensitive-data-->--> -->-->If there are ethical, legal, or third-party restrictions upon your dataset, you must provide all of the following details (https://journals.plos.org/plosone/s/data-availability#loc-acceptable-data-access-restrictions):-->-->a) A complete description of the dataset-->-->b) The nature of the restrictions upon the data (ethical, legal, or owned by a third party) and the reasoning behind them-->-->c) The full name of the body imposing the restrictions upon your dataset (ethics committee, institution, data access committee, etc)-->-->d) If the data are owned by a third party, confirmation of whether the authors received any special privileges in accessing the data that other researchers would not have-->-->e) Direct, non-author contact information (preferably email) for the body imposing the restrictions upon the data, to which data access requests can be sent-->--> -->-->4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.-->?> [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: No Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: I Don't Know Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: No Reviewer #2: Yes ********** Reviewer #1: The manuscript is significantly longer than a typical journal article, which may impact readability and adherence to journal guidelines. The content needs significant condensation, with a focus on the core findings and removal of unnecessary details. A more concise presentation of the key findings and arguments would enhance clarity and accessibility for readers. I recommend restructuring or condensing sections where possible while maintaining the integrity of the study. Consider focusing on the most essential details and streamlining discussions to improve the manuscript’s overall impact. Reviewer #2: Thank you for the opportunity to review this manuscript, which presents a valuable study on determining key intervention elements for pre-school children with co-occurring SSD and DLD. The retention of participants is impressive, and the inclusion of a diverse range of parties throughout the entire process strengthens the findings. Additionally, the clear goal of translating these results into clinical guidelines is an important contribution to the field. However, while the paper provides useful insights, it would benefit from more specific examples and definitions of key terms and phrases. Although some readers may be familiar with the theories and concepts discussed, since this manuscript is being submitted to PLOS One rather than a speech-specific journal, I recommend that certain terms be more explicitly defined for a broader audience. Please see attached comments for more specific feedback. I look forward to following this work. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Dear Dr. Rodgers, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== Please respond all comments and highlight them in the revised ms. ============================== Please submit your revised manuscript by Jun 29 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Thiago P. Fernandes, PhD Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #2: (No Response) Reviewer #3: (No Response) Reviewer #4: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** Reviewer #2: Thank you for the thorough revisions. The manuscript now provides greater clarity in its framing and use of terminology, and the expanded methodological detail strengthens the transparency of the study. I particularly appreciate the added context regarding the role of stakeholders and the clarification of the e-Delphi process. At this stage, I have only a few remaining suggestions. These are included in the Reviewer Attachments. This study makes an important contribution to the literature on intervention development for children with co-occurring SSD and DLD, and I look forward to seeing it published and informing future clinical work. Reviewer #3: Thank you for the opportunity to review this work! The development of intervention programs targeting both speech and language is a valuable and much-needed contribution to the field. Overall, this is a compelling project, and I appreciated the opportunity to read it. I’ve noted several areas where further clarification or editing may be helpful, and I hope these comments support your efforts to strengthen the manuscript even further. Line 84: You introduce the term ‘phonological SSDs’. It would be helpful to clarify whether you are distinguishing between phonological and articulation disorders throughout the paper, or simply noting that SSDs can have a phonological component. As you know, many children with SSDs present with both articulatory and phonological impairments. This distinction is important, as it was unclear at times whether references to SSDs throughout the manuscript were meant to include all types or specifically phonological SSDs. For instance, at Line 237, it’s not clear whether panelists were instructed to consider only phonological SSDs when reviewing the statements. In the discussion (Line 433), you refer to children with “consistent phonological SSD”, a term not previously defined or used in the paper. The manuscript would benefit from a clear statement early on about whether your focus is exclusively on children with consistent phonological disorder. If so, consider assigning a specific term (e.g., P-SSD) to differentiate it from SSDs more broadly, and revise relevant sections in the introduction, methods, and discussion accordingly. Line 85: As currently written, the sentence suggests that speech comprehensibility is defined as “frustrations at not being understood by others around them,” which is somewhat misleading. A clearer definition of speech comprehensibility would benefit the reader. It may also be useful to briefly contrast comprehensibility with intelligibility, since intelligibility typically refers to the accuracy of speech sounds, whereas comprehensibility relates more to the listener’s ability to derive meaning from the overall message. Additionally, clarifying why comprehensibility was chosen over intelligibility in this context would strengthen this section. Line 95: The phrase “referred to in day-to-day practice” is a bit vague, and the sentence reads as somewhat long. If your point is that these protocols are not commonly implemented, a clearer version might be: “However, clinical research suggests that intervention protocols are not strictly implemented in day-to-day practice. Instead, speech and language therapists…” Line 98: It would be helpful to include an example to illustrate what is meant by the “infeasibility of delivery in public services” and the competing priorities clinicians face. This is a strong point in your argument, emphasizing the importance of including SLTs in intervention development, and could be further strengthened with a more detailed description of these barriers. Line 156: Did you mean “a priori” here? If so, consider adjusting the phrasing for accuracy. Lines 183–190: I commend you for assembling such a diverse team of contributors. Including both a parent of a child with DLD and an adult with DLD adds valuable perspectives that enrich the development process. Table 1: Is Miro board widely known among your intended readership? This may just be a lack of knowledge on my part, but I had to look it up myself, so it may be helpful to briefly explain what it is or why it was used, or use a more common term (whiteboard) that describes the same idea. Line 340: You mention 36 panelists but describe the main employer for only 35. Could you clarify what information is available for the remaining participant? Table 2, Row 1: Should this be phrased as “agree on the child’s targets” and “by agreeing on the child’s targets”? It may be a dialect difference, but I found the current wording slightly unclear. Table 2, Statement 26: There appears to be a typo in the rationale: “enable to parent” should likely be “enable the parent.” Table 2, Statement 20: This is the first use of the abbreviation SLT, which I don’t believe has been defined earlier in the paper. Consider introducing the term when it first appears and using throughout, or changing this instance. Table 2, Statement 47: This is the only statement formatted with “Statement 47” preceding the text, whereas others list only the number in parentheses. Table 3, Row 1: I believe there is a typo in the reworded statement where “area” should likely be “are.” Table 1 (Behavior Change Techniques): The first mention of behavior change techniques and behavior change technique ontology appears in the Methods section. Since these are central to your intervention design, consider introducing them earlier in the Introduction to help the reader understand their significance. Line 421: When discussing the tension between service delivery and feasibility, could you specify which panelist responses reflected this tension? Providing explicit examples would strengthen your argument. Line 423: The phrase “flexibility relating to deliverer” is unclear. Do you mean flexibility regarding how intervention is delivered or the type of intervention, or? A more explicit phrasing would improve comprehension. Line 447: Could you clarify which specific findings you are referring to here? Although I understand what you are getting at, being more explicit would make this section more impactful and easier to follow. Line 462: You note both a change in how statements were worded and a shift in how participants were asked to consider them (e.g., setting aside limitations of their own service). How can you be confident that the change in responses was due to the instruction rather than the rewording itself? It may be worth addressing this potential confound. Line 494: Although your phrasing of this limitation is acceptable, I would argue that the limitation lies less in the number of panelists (as you reached your recruitment target) and more in the uneven representation of different service delivery models among them. Reviewer #4: Thank you for the opportunity to review this important work. The stated purpose of this study was to achieve consensus on core intervention approaches that are specific to DLD and SSD. The research question is well motivated and justified and the findings make a significant contribution to the literature surrounding intervention approaches in children who have concomitant speech and language difficulties. This work is especially important in light of the CATALISE reclassification of DLD, which highlights phonology as an important interface between DLD and SSD. As a DLD researcher myself, the relation between DLD and SSD is understudied, so this work advances an important topic of discussion. In my view, this work is well positioned at the crux of a high-impact question that is of great interest to the field. I commend the authors on tackling this important question and believe this work will be of great interest to the readership of this journal. While this is more specific to speech and language intervention, the types of intervention components are translatable to multiple clinical populations and the Delphi method is well explained. The methodological detail, while lengthy, provides a useful model for researchers following the Delphi method to conduct systematic and rigorous inquiry into clinical questions. In light of my examination of the previous reviews and author responses, my comments are minor and are offered to improve readability and add to this important question. Introduction: Between lines 84-121 the authors discuss shared deficits in phonology between DLD and SSD. In my view, this section would be enhanced with a few statements on some of the research related to the mechanistic ties that might support overlapping areas of deficits. What comes to mind is recent work in sequence learning in DLD by Goffman & Gerken (2023), Benham et al., (2018), and Benham & Goffman (2022) To an extent, the procedural deficit hypothesis (Ullman & Pierpont, Ullman & Pullman) may also be a useful rationale for bridging these areas. While the work in this manuscript is not theoretical in nature, a brief discussion of some of this work may provide a useful framework for motivating the ‘theory-based intervention approaches’ you address below. Some recommended citations for consideration are: Goffman, L., & Gerken, L. (2023). A developmental account of the role of sequential dependencies in typical and atypical language learners. Cognitive Neuropsychology, 40(5-6), 243-264. Benham, S., Goffman, L., & Schweickert, R. (2018). An application of network science to phonological sequence learning in children with developmental language disorder. Journal of Speech, Language, and Hearing Research, 61(9), 2275-2291 . Benham, S., & Goffman, L. (2022). A longitudinal study of the phonological organisation of novel word forms in children with developmental language disorder. International journal of speech-language pathology, 24(2), 212-223. Methods: The authors use the term “Behaviour Change Technique” quite a bit, but I found this lacking a definition. Some examples would also be helpful. It would be helpful to define this around line 229 so readers can understand why this is a core part of the intervention process. Table 2 would benefit from having the number of the statement on the side to the left so that it is easier to refer back to. On Table 3, it would be useful to add the values of consensus to the table instead of just reporting that no consensus was reached. It would be of interest to know how far off the agreement was for these statements. The rate of attrition is impressive. Did the participant who dropped out provide a reason or just did not respond to the round 2 survey? Discussion I am curious about the distinction the authors make between articulatory-based deficits and phonological-based speech sound deficits. I find that this line can often be exceptionally vague, but this work seems to take an approach that is broad and can be applied to a number of SSDs. I think this section would benefit from a brief discussion of the application of these statements to various SSDs around line 436 when the authors mention consistent phonological SSDs. Often children with CAS, who are less consistent, also exhibit language deficits, so I am curious whether these statements would be applicable to special populations who exhibit less consistency. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #2: No Reviewer #3: No Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org
|
| Revision 2 |
|
Co-design to consensus: identifying the core elements of a novel intervention for pre-school children with co-occurring phonological speech sound disorder (SSD) and developmental language disorder (DLD) using a modified e-Delphi approach PONE-D-24-58856R2 Dear Dr. Rodgers, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Thiago P. Fernandes, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Thank you for your careful and thoughtful edits. The ms reads much better now - but please double check grammar and refs list to help streamline typesetting. Wishing you success with the study. Reviewers' comments: |
| Formally Accepted |
|
PONE-D-24-58856R2 PLOS ONE Dear Dr. Rodgers, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Thiago P. Fernandes Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .